For millions of people worldwide, the diagnosis of actinic keratosis (AK)—the rough, scaly, sun-induced patches that serve...
Treatment Innovations
In a significant move for neurosurgical innovation, Massachusetts-based medical device developer CereVasc has successfully closed an $85...
In a move that underscores the rapidly accelerating integration of artificial intelligence into the pharmaceutical sector, RNA-focused...
In the rapidly evolving landscape of metabolic health, Eli Lilly has reached a new, albeit complex, milestone....
In a move designed to reshape the landscape of minimally invasive surgery, Medtronic has announced a significant...
In a landmark deal that signals a shift toward the "industrialization" of regenerative medicine, Cellular Intelligence—formerly known...
Massachusetts-based medical technology innovator CereVasc has successfully closed a significant $85 million Series C financing round, marking...
Introduction: The Convergence of RNA Interference and Artificial Intelligence The pharmaceutical landscape is undergoing a profound transformation,...
In a historic shift for the global pharmaceutical landscape, Canada has officially become the first G7 nation...
In a significant consolidation within the sleep technology sector, California-based medical device giant ResMed has announced the...
